ghk cu skin transformation systemic 6 month GHK-CU check-in Main takeaway: takes time. GHK End of Week 1: GHK-CU

However, preclinical studies demonstrate therapeutic effects with once-daily or even less frequent administration, suggesting tissue distribution, receptor binding, or cellular signaling effects extend beyond plasma clearance

A peptide procured via a Telegram vendor in a nondescript vial is almost certainly neither

In September 2023 the FDA placed BPC-157 in Category 2 of its 503A interim bulk-substances policy, citing immunogenicity and peptide-characterization concerns, effectively excluding it from the 503A compounding bulk-substances list

The FDA meeting is about access, not efficacy, but the grifters will sell the difference